Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-03-06
1987-07-28
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544335, A61K 31505, C07D23920
Patent
active
046832343
ABSTRACT:
N-substituted 3,4-dihydropyrimidine derivatives of the formula: ##STR1## wherein X.sup.1, X.sup.2 and X.sup.3 are the same or different and are hydrogen, nitro, halogen, cyano, trifluoromethyl, methylthio or lower alkoxy;
REFERENCES:
patent: 4048171 (1977-09-01), Bossert et al.
patent: 4285955 (1981-08-01), Wehinger et al.
Merck Index, 6352, Nifedipine.
Goerlitzer et al., Chem. Abst. 96-85501u.
Goerlitzer et al., Arch. Pharm. 1981, 314(11), 938-949.
Iwanami et al., Chem. Abst. 86-43570d.
Zidermane et al., Chem. Abst. 75-47266e.
Stoltefuss et al., Chem. Abst. 101-55110 eq. DE 3234684.
Aisaka Kazuo
Cho Hidetsura
Ishihara Takafumi
Sato Fumio
Daus Donald G.
Shen Cecilia
Suntory Limited
LandOfFree
2,6-Dimethyl-3N,5-disubstituted-4-(substituted phenyl)3,4-dihydr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,6-Dimethyl-3N,5-disubstituted-4-(substituted phenyl)3,4-dihydr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,6-Dimethyl-3N,5-disubstituted-4-(substituted phenyl)3,4-dihydr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2035057